• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

    7/10/24 9:05:59 AM ET
    $GKOS
    $HELE
    $LZ
    $SPOT
    Medical/Dental Instruments
    Health Care
    Home Furnishings
    Consumer Discretionary
    Get the next $GKOS alert in real time by email

    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

    • Redburn Atlantic analyst Agnieszka Pustula downgraded the rating for Spotify Technology S.A. (NYSE:SPOT) from Neutral to Sell and announced a price target of $230. Spotify shares fell 0.7% to close at $311.55 on Tuesday. See how other analysts view this stock.
    • B of A Securities analyst Jason Kupferberg downgraded Visa Inc. (NYSE:V) from Buy to Neutral, while cutting the price target from $305 to $297. Visa shares fell 0.4% to close at $265.44 on Tuesday. See how other analysts view this stock.
    • DA Davidson analyst Linda Bolton Weiser downgraded the rating for Helen of Troy Limited (NASDAQ:HELE) from Buy to Neutral, while lowering the price target from $139 to $67. Helen Of Troy shares dipped 27.7% to close at $64.33 on Tuesday. See how other analysts view this stock.
    • JP Morgan analyst Ella Smith downgraded LegalZoom.com, Inc. (NASDAQ:LZ) from Overweight to Neutral and lowered the price target from $14 to $9. LegalZoom shares fell 1.5% to settle at $7.85 on Tuesday. See how other analysts view this stock. See how other analysts view this stock.
    • Citigroup analyst Joanne Wuensch downgraded the rating for Glaukos Corporation (NYSE:GKOS) from Buy to Neutral, while raising the price target from $130 to $132. Glaukos shares fell 0.7% to close at $121.75 on Tuesday. See how other analysts view this stock.

    Check This Out:

    • Delta Air Lines Likely To Report Lower Q2 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts
    Get the next $GKOS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GKOS
    $HELE
    $LZ
    $SPOT

    CompanyDatePrice TargetRatingAnalyst
    Spotify Technology S.A.
    $SPOT
    2/11/2026$875.00 → $420.00Buy → Hold
    Pivotal Research Group
    Visa Inc.
    $V
    2/3/2026$370.00Neutral → Outperform
    Daiwa Securities
    Spotify Technology S.A.
    $SPOT
    1/30/2026$650.00Neutral → Buy
    Citigroup
    Visa Inc.
    $V
    1/28/2026$385.00Neutral → Buy
    Rothschild & Co Redburn
    Visa Inc.
    $V
    1/27/2026$400.00Overweight
    Cantor Fitzgerald
    Spotify Technology S.A.
    $SPOT
    1/27/2026$487.00Neutral
    MoffettNathanson
    Spotify Technology S.A.
    $SPOT
    1/23/2026$700.00Neutral → Buy
    Goldman
    Spotify Technology S.A.
    $SPOT
    12/17/2025$800.00Mkt Outperform
    Citizens JMP
    More analyst ratings

    $GKOS
    $HELE
    $LZ
    $SPOT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Spotify downgraded by Pivotal Research Group with a new price target

    Pivotal Research Group downgraded Spotify from Buy to Hold and set a new price target of $420.00 from $875.00 previously

    2/11/26 9:23:52 AM ET
    $SPOT
    Broadcasting
    Consumer Discretionary

    Visa upgraded by Daiwa Securities with a new price target

    Daiwa Securities upgraded Visa from Neutral to Outperform and set a new price target of $370.00

    2/3/26 7:57:45 AM ET
    $V
    Real Estate

    Spotify upgraded by Citigroup with a new price target

    Citigroup upgraded Spotify from Neutral to Buy and set a new price target of $650.00

    1/30/26 6:41:31 AM ET
    $SPOT
    Broadcasting
    Consumer Discretionary

    $GKOS
    $HELE
    $LZ
    $SPOT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    LegalZoom Reports Strong Fourth Quarter and Full Year 2025 Financial Results

    Q4 2025 revenue and Adjusted EBITDA exceeds outlook Introduces strong 2026 guidance Announces $100 million increase to share repurchase authorization Full-year revenue of $756.0 million up 11% year-over-year, reflecting emphasis on subscription initiatives and contributions from the Formation Nation acquisition    Full-year subscription revenue of $492.5 million up 13% year-over-year, driven by focus on higher-value customers and differentiated human-in-the-loop service offerings Full-year net income of $15.4 million and net income margin of 2% Full-year Adjusted EBITDA of $172.2 million and Adjusted EBITDA margin of 23%Record full-year operating cash flow of $178.2 million, up 31% year-o

    2/19/26 4:00:00 PM ET
    $LZ
    EDP Services
    Technology

    Advent to Sell Prisma and Newpay to Visa

    Advent International, a leading global private equity investor, today announced that it has entered into a definitive agreement to sell Prisma and Newpay, subsidiaries of Group Prisma, a leading Argentine payments company, to Visa (NYSE:V). During Advent's ownership, the group underwent a strategic transformation, resulting in the separation of the business into three focused and independent platforms — Prisma, Newpay, and Payway. This transaction represents the sale of two of the three platforms, with Advent retaining ownership of Payway, the group's merchant acquiring business. Prisma is an issuer processing platform in Argentina, processing more than six billion transactions annually

    2/19/26 9:13:00 AM ET
    $V
    Real Estate

    Visa to Acquire Prisma Medios de Pago and Newpay in Argentina

    Visa (NYSE:V) today announced that it has entered into a definitive agreement to acquire Prisma Medios de Pago S.A.U. ("Prisma") and Newpay S.A.U. ("Newpay") in Argentina from Advent International. This strategic acquisition underscores Visa's commitment to providing clients with the advanced capabilities and technologies that accelerate the adoption of innovative payment solutions for consumers and businesses across the country. Prisma provides credit, debit and prepaid card issuer processing. Newpay is a multi-network infrastructure provider that operates real-time payments services, the Banelco ATM network and the bill payment platform PagoMisCuentas. Upon closing, the combined techn

    2/19/26 9:08:00 AM ET
    $V
    Real Estate

    $GKOS
    $HELE
    $LZ
    $SPOT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer & CFO Watson Noel Bertram sold $104,414 worth of shares (15,000 units at $6.96), decreasing direct ownership by 1% to 1,480,860 units (SEC Form 4)

    4 - LEGALZOOM.COM, INC. (0001286139) (Issuer)

    2/19/26 5:57:36 PM ET
    $LZ
    EDP Services
    Technology

    Chief Operating Officer & CFO Watson Noel Bertram covered exercise/tax liability with 55,722 shares, decreasing direct ownership by 4% to 1,495,860 units (SEC Form 4)

    4 - LEGALZOOM.COM, INC. (0001286139) (Issuer)

    2/18/26 6:21:40 PM ET
    $LZ
    EDP Services
    Technology

    Chief Executive Officer Stibel Jeffrey M covered exercise/tax liability with 78,357 shares, decreasing direct ownership by 3% to 2,207,709 units (SEC Form 4)

    4 - LEGALZOOM.COM, INC. (0001286139) (Issuer)

    2/18/26 6:21:34 PM ET
    $LZ
    EDP Services
    Technology

    $GKOS
    $HELE
    $LZ
    $SPOT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Judge Tessa bought $9,948 worth of shares (435 units at $22.87), increasing direct ownership by 2% to 24,812 units (SEC Form 4)

    4 - HELEN OF TROY LTD (0000916789) (Issuer)

    7/16/25 7:19:24 PM ET
    $HELE
    Home Furnishings
    Consumer Discretionary

    Chief Executive Officer Grass Brian bought $214,700 worth of shares (10,000 units at $21.47), increasing direct ownership by 8% to 135,932 units (SEC Form 4)

    4 - HELEN OF TROY LTD (0000916789) (Issuer)

    7/15/25 6:38:30 PM ET
    $HELE
    Home Furnishings
    Consumer Discretionary

    Chief Financial Officer Scheuerman Tracy bought $201,300 worth of shares (10,000 units at $20.13), increasing direct ownership by 43% to 33,041 units (SEC Form 4)

    4 - HELEN OF TROY LTD (0000916789) (Issuer)

    7/15/25 6:38:05 PM ET
    $HELE
    Home Furnishings
    Consumer Discretionary

    $GKOS
    $HELE
    $LZ
    $SPOT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for IDOSE TR issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug IDOSE TR (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/15/23 11:41:09 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    FDA Approval for TRAVOPROST issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug TRAVOPROST (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/14/23 7:41:03 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $GKOS
    $HELE
    $LZ
    $SPOT
    SEC Filings

    View All

    LegalZoom.com Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - LEGALZOOM.COM, INC. (0001286139) (Filer)

    2/19/26 4:04:26 PM ET
    $LZ
    EDP Services
    Technology

    Glaukos Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - GLAUKOS Corp (0001192448) (Filer)

    2/17/26 4:10:25 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    SEC Form 425 filed by Visa Inc.

    425 - VISA INC. (0001403161) (Subject)

    2/13/26 8:48:05 AM ET
    $V
    Real Estate

    $GKOS
    $HELE
    $LZ
    $SPOT
    Leadership Updates

    Live Leadership Updates

    View All

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate

    Visa Foundation Board Appoints Najada Kumbuli as President of Visa Foundation

    Visa (NYSE:V), a global leader in digital payments, today announced that Najada Kumbuli has been appointed President of Visa Foundation, effective immediately. With guidance from the Board, Kumbuli will be responsible for managing Visa Foundation's impact investing and grantmaking, and will also serve as Visa Inc.'s head of global philanthropy. Kumbuli has more than 15 years of experience in investment strategy, impact evaluation, and leadership of global philanthropic programs. Prior to Visa Foundation, she served as the Investment Director at Calvert Impact Capital, a global impact investment firm. Kumbuli succeeds Graham Macmillan, who served as Visa Foundation's president since 2019.

    12/11/25 10:30:00 AM ET
    $V
    Real Estate

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    $GKOS
    $HELE
    $LZ
    $SPOT
    Financials

    Live finance-specific insights

    View All

    LegalZoom Reports Strong Fourth Quarter and Full Year 2025 Financial Results

    Q4 2025 revenue and Adjusted EBITDA exceeds outlook Introduces strong 2026 guidance Announces $100 million increase to share repurchase authorization Full-year revenue of $756.0 million up 11% year-over-year, reflecting emphasis on subscription initiatives and contributions from the Formation Nation acquisition    Full-year subscription revenue of $492.5 million up 13% year-over-year, driven by focus on higher-value customers and differentiated human-in-the-loop service offerings Full-year net income of $15.4 million and net income margin of 2% Full-year Adjusted EBITDA of $172.2 million and Adjusted EBITDA margin of 23%Record full-year operating cash flow of $178.2 million, up 31% year-o

    2/19/26 4:00:00 PM ET
    $LZ
    EDP Services
    Technology

    Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results

    Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced financial results for the fourth quarter and full year ended December 31, 2025. Key highlights include: Record net sales of $143.1 million in Q4 2025 increased 36% year-over-year on a reported basis and 34% year-over-year on a constant currency basis. Glaucoma record net sales of $119.2 million in Q4 2025 increased 42% year-over-year. U.S. Glaucoma record net sales of $86.4 million in Q4 2025 increased 53% year-over-year. Net sales of $507.4 million in 2025 increased 32% yea

    2/17/26 4:05:00 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    LegalZoom to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026

    MOUNTAIN VIEW, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- LegalZoom.com, Inc. (NASDAQ:LZ), a leading online platform for legal services, today announced it will report its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, February 19, 2026, after the close of market. Jeff Stibel, Chairman and Chief Executive Officer, and Noel Watson, Chief Operating Officer and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET the same day to discuss the financial results. LegalZoom Fourth Quarter and Full Year 2025 Conference Call Details Date:Thursday, February 19, 2026  Time:4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)  Webc

    1/29/26 9:00:00 AM ET
    $LZ
    EDP Services
    Technology

    $GKOS
    $HELE
    $LZ
    $SPOT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Helen of Troy Limited

    SC 13G/A - HELEN OF TROY LTD (0000916789) (Subject)

    11/14/24 3:53:05 PM ET
    $HELE
    Home Furnishings
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Glaukos Corporation

    SC 13G/A - GLAUKOS Corp (0001192448) (Subject)

    11/14/24 1:21:45 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Helen of Troy Limited

    SC 13G/A - HELEN OF TROY LTD (0000916789) (Subject)

    11/12/24 3:49:29 PM ET
    $HELE
    Home Furnishings
    Consumer Discretionary